Interested in learning more about PathoQuest’s NGS solution for safety testing in association with cellular and gene therapy manufacturing ?  Contact us to arrange a meeting with Jean-Marie Charpin, Ph.D., PathoQuest’s Global Commercial Head for Bioproduction Safety, during the upcoming 25th Annual Congress of the European Society of Gene and Cell therapy (ESGCT) being held on October 18-20 in Berlin, Germany.